Regis Healthcare Shares Soar on Strong H1 Earnings

Earnings Propel Stock Surge

Shares of Australia’s Regis Healthcare Ltd surged significantly following the release of its first-half financial results. The aged-care provider reported substantial revenue growth driven by stronger occupancy and recent acquisitions, boosting investor confidence.

Financial Performance Overview

For the six months ending December 31, Regis Healthcare saw revenue from services climb 18% year-on-year to A$667.7 million. Underlying EBITDA increased 4% to A$70.6 million. Underlying net profit after tax was broadly unchanged at A$29.7 million, as higher wage and expansion costs offset the revenue gains.

Market Reaction and Outlook

Following the announcement, the company's Sydney-listed shares rose as much as 12%. The board also declared an increased fully franked interim dividend of 9.0 Australian cents per share. Regis forecasts an FY26 underlying EBITDA between A$130 million and A$135 million, reiterating its growth target of 10,000 beds by FY28.

Summary

Regis Healthcare's strong operational performance has translated into positive market sentiment, reflected in its sharp share price increase and a higher dividend for shareholders. The company's forward guidance suggests a continued focus on expansion and profitability.

FAQ

Q: Why did Regis Healthcare's stock price increase?
A: The stock rose due to a strong first-half earnings report, which highlighted an 18% revenue increase and improved occupancy rates.

Q: What was the dividend announced by Regis Healthcare?
A: The board declared a fully franked interim dividend of 9.0 Australian cents per share, up from 8.0 cents in the previous year.

Source: Investing.com